N05BA04 oxazepam
NERVOUS SYSTEM ›PSYCHOLEPTICS ›ANXIOLYTICS ›Benzodiazepine derivatives
健保收載品項 TFDA 在效許可證 6 FDA 已核准
台灣藥品與外觀
健保收載品名："信隆" 賜靜膠囊１０公絲（歐沙挫那）、"十全" 歐慮平錠、"應元"施舒錠30毫克、安慮平錠１５毫克、安樂平錠３０公絲、安立平錠15 毫克、懊去散錠、輔舒靜糖衣錠１０公絲
無外觀照
歐沙氮平
資料來源：食藥署「西藥許可證」＋「藥品 ATC 碼」＋「藥品外觀」＋「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。
適應症
台灣 TFDA 核准適應症
- 焦慮狀態。
- 寧神劑。
- 寧神藥。
美國 FDA 適應症（英文原文對照）
INDICATIONS Oxazepam capsules are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. Anxiety associated with depression is also responsive to oxazepam therapy. This product has been found particularly useful in the management of anxiety, tension, agitation and irritability in older patients. Alcoholics with acute tremulousness, inebriation, or with anxiety associated with alcohol withdrawal are responsive to therapy. The effectiveness of oxazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
資料來源：食藥署西藥許可證適應症（中文）、openFDA US SPL（英文，僅供對照）。
健保給付規定
查無健保特殊給付規定條款；本藥品依一般健保藥品支付規定給付。
實證補充
本藥品尚無實證補充整理（未來新增 Review／指引知識時補列）。
台灣藥品與適應症：食藥署西藥許可證＋ATC＋外觀＋仿單開放資料 · FDA：openFDA US SPL · 健保給付：健保署「全民健康保險藥品給付規定」（更新日 2026-06-09）· 實證補充：人工彙整。 本頁為資訊整理，實際給付與適應症以主管機關公告為準。